SciNeuro Pharmaceuticals
St. Louis, United States· Est.
SciNeuro Pharmaceuticals develops novel therapies for central nervous system disorders, focusing on neurodegenerative and neuropsychiatric diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $53M
About
SciNeuro Pharmaceuticals develops novel therapies for central nervous system disorders, focusing on neurodegenerative and neuropsychiatric diseases.
Neuroscience
Funding History
1Total raised:$53M
PIPE$53M